Total body irradiation-based myeloablative conditioning for acute lymphoblastic leukaemia patients undergoing allogeneic haematopoietic stem cell transplantation: the best way to prevent relapse in a real-world scenario.

Ther Adv Hematol · 2025 · PMC11770703 · PMID 39872009

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In fact, when analysing only TBI-based allotransplants, CR1 showed a trend in favour of better OS-outcome (5-year OS: 57% (CR1) vs 41% (CR⩾2), Table 1 ) thus confirming the exclusive OS-benefit from CR1 when the conditioning regimen was a TBI-based one.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.